NCB-0846 (Standard)
NCB-0846 (Standard) is the analytical standard of NCB-0846. This product is intended for research and analytical applications. NCB-0846 is an orally active, selective inhibitor for Wnt, that inhibits Traf2- and Nck-interacting kinase (TNIK) with an IC50 of 21 nM. NCB-0846 blocks TGF-β signaling pathway by inhibiting SMAD2/3 phosphorylation and nuclear translocation[1][2].
Product Specifications
CAS Number
1792999-26-8
Target
MAP4K; Reference Standards; TGF-beta/Smad; Wnt
Related Pathways
MAPK/ERK Pathway; Others; Stem Cell/Wnt; TGF-beta/Smad
Field of Research
Cancer
Smiles
O[C@@H](CC1)CC[C@@H]1OC2=CC=CC(C=N3)=C2N=C3NC4=CC=C(N=CN5)C5=C4
Molecular Formula
C21H21N5O2
Molecular Weight
375.42
References & Citations
[1]Masuda M, et al. TNIK inhibition abrogates colorectal cancer stemness. Nat Commun. 2016 Aug 26;7:12586.|[2]Sugano T, et al., Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846. Br J Cancer. 2021 Jan;124 (1) :228-236.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2557580-01 0.01 mg
Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 Protein (C-His)
Sign In for Pricing
View Details MBS2557580-02 0.05 mg
Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 Protein (C-His)
Sign In for Pricing
View Details MBS2557580-03 5x 0.05 mg
Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 Protein (C-His)
Sign In for Pricing
View Details